Cross-sectorial Rehabilitation of Patients with Lung Cancer
Recruiting
N/A
Interventional Study
Lung Cancer Non-Small Cell Cancer (NSCLC)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 130 (estimated)
- Sponsor
- Camilla Balle · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Four thousand seven hundred patients are diagnosed with lung cancer in Denmark every year. Even though cigarette smoking has declined for decades a decline in lung cancer incidence is still at least a decade away. Only 16% of these patients with lung cancer started in a municipal rehabilitation program.
Aim: To investigate if the intervention "early contact conference" can facilitate acceptance o…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* patients diagnosed with NSCLC
* 1\. line systemic treatment
Exclusion Criteria:
* cannot speak, understand, and/or read Danish
* cognitive/psychologically unfit to give consent
Contacts